Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-15

Clinical Trial Update: A Post-Market Clinical Evaluation of the Treatment of Femur Fractures With the Femoral Nail GT

View source ↗

Summary

Post-market clinical evaluation of the Femoral Nail GT for treating femur fractures; sponsored by Stryker, with the study currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Femoral Nail GT

Snippet

Sponsor: Stryker Trauma and Extremities | Conditions: Femoral Fracture | Status: ACTIVE_NOT_RECRUITING